Exogenous SLFN12 reduces in vivo TNBC proliferation and invasion, increases luminal markers and a gene signature that reducts better breast cancer survival in cohort database analysis
收藏NIAID Data Ecosystem2026-03-14 收录
官方服务：
资源简介：
Our results suggest that increased SLFN12 expression modulates TNBC aggressiveness through a gene signature which could offer new targets for treatment. Overall design: Human TNBC tumor xenografts with exogenous SLFN12 expression were created and the growth was observed and then RNA-seq was performed to investigate pathways related to SLFN12
创建时间：
2023-01-26
